Mandate
Hear and make a determination of a matter referred to the committee regarding a pharmacist’s or pharmacy technician’s conduct, competency and/or ability to practice, pursuant to legislation.
Membership
Derek Lee (Chair)
Heather Baxter (Vice-Chair)
David Pavan (staff resource)
Rapinder Chahal
Wayne Chen
Jody Croft
Dianne Cunningham
Baldeep Dhillon
Anneke Driessen
Nerys Hughes
Edwin Kry
Howard Kushner
Peter Lam
Derek Lee
Dominique Marcotte
Leza Muir
Anne Peterson
Annette Robinson
Omar Saad
Sophie Sanfacon
Gurinder Saran
Paulo Tchen
Jeremy Walden
Carol Williams
Amparo Yen
Number of Meetings
Number of hearing days/teleconferences: 0
Number of files in progress:1
Number of discipline files heard in court: 0
Number of pending files: 4
Number of files completed: 3
Summary
Isodoro Andres “Rudy” Sanchez / Marigold Compounding and Natural Pharmacy and Marigold Natural Pharmacy Ltd.
On June 1, 2018, a Panel of the Discipline Committee, pursuant to sections 39(1)(a) and 39(1)(c) of the Health Professions Act, found that registrant Isidoro Andres “Rudy” Sanchez engaged in unprofessional conduct and failed to comply with the Health Professions Act, its regulations and bylaws and the Pharmacy Operations and Drug Scheduling Act and its bylaws.
Pursuant to section 39(2) of the Health Professions Act, the Panel issued an order to immediately cancel the Mr. Sanchez’s registration and for the Registrant to pays costs in the amount of $115,000.00. He will only be eligible to apply for reinstatement of registration six years following the Panel’s order and after having paid costs in full. If his registration is reinstated, he will not be eligible to apply for a pharmacy license or act as a pharmacy manager or director for a period of five years following reinstatement.
William Byron Sam
The Inquiry Committee directed the Registrar of the College to issue a citation against registrant William Byron Sam in 2016. Mr. Sam is the manager and director of Garlane Pharmacy #2 where he failed to cooperate with the College in its operation of Quality Assurance Program and in its investigation pursuant of Part 3 of the Health Professions Act.
Hearings were held on the following dates:
- May 19, 2017
- August 22, 2017
- March 1, 2018
A decision is pending.